Get the Stockscreener App
17.68
0.40%
0.07
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $17.68, with a volume of 2.95M.
It is up +0.40% in the last 24 hours and up +1.61% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
See More
Previous Close:
$17.61
Open:
$17.56
24h Volume:
2.95M
Relative Volume:
0.08
Market Cap:
$33.95B
Revenue:
$15.12B
Net Income/Loss:
$1.47B
P/E Ratio:
23.14
EPS:
0.764
Net Cash Flow:
$1.72B
1W Performance:
+2.43%
1M Performance:
+1.61%
6M Performance:
+18.18%
1Y Performance:
-24.41%
1-Day Range:
$17.53
$17.71
1-Week Range:
$17.13
$17.80
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.68 | 33.81B | 15.12B | 1.47B | 1.72B | 0.764 |
PG
Procter Gamble Co
|
145.53 | 341.47B | 85.26B | 16.53B | 14.85B | 6.7488 |
UL
Unilever Plc Adr
|
58.13 | 127.82B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
84.11 | 68.85B | 20.38B | 2.26B | 3.63B | 2.6214 |
KMB
Kimberly Clark Corp
|
99.20 | 32.81B | 17.23B | 1.75B | 1.64B | 6.0654 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue Inc. $KVUE Stock Holdings Raised by Mayar Capital Ltd. - MarketBeat
Institute for Wealth Management LLC. Invests $1.09 Million in Kenvue Inc. $KVUE - MarketBeat
Listerine Cool Mint: Oral Care Staple Faces Evolving Consumer Demands - AD HOC NEWS
How Elevating Its Chief Accounting Officer To Interim CFO At Kenvue (KVUE) Has Changed Its Investment Story - simplywall.st
Listerine Cool Mint: Why oral care demand surges amid health trends - AD HOC NEWS
The Smartest Dividend Stocks to Buy With $2,000 Right Now - The Motley Fool
KBC Group NV Sells 177,863 Shares of Kenvue Inc. $KVUE - MarketBeat
CWC Advisors LLC. Takes $1.68 Million Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Says Shea & Cocoa Butter Oil Is Accurately Labeled - Law360
Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal - MSN
CFOs On the Move: Week ending April 17 - CFO.com
Kenvue: Extremely Mature Merger Target Is Too Expensive (NYSE:KVUE) - Seeking Alpha
Kimberly-Clark keeps Urdaneta as CFO of combined company - CFO Dive
Kimberly-Clark discloses post-closing leadership structure - Mass Market Retailers
Kimberly-Clark Maps Kenvue Integration As Valuation Suggests Upside Potential - Yahoo Finance
Kimberly-Clark's new structure sets stage for Kenvue integration - MSN
Are Options Traders Betting on a Big Move in Kenvue Stock? - Yahoo Finance
Kimberly-Clark's New Structure Sets Stage for Kenvue Integration - Yahoo Finance
Wealth Effects LLC Increases Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark names leadership team for Kenvue acquisition By Investing.com - Investing.com India
Kimberly-Clark shares tick higher after post-acquisition leadership plans revealed - MSN
Kimberly-Clark To Acquire Kenvue In Massive $48.7B Merger - MSN
Kenvue (NYSE:KVUE) Given New $19.00 Price Target at Citigroup - MarketBeat
EQUITY INVESTMENT CORP's Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue Inc (KVUE) Stock Price Quote Today & Current Price Chart - Capital.com
Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal - WSJ
Kenvue names Heather Howlett as interim CFO following Amit Banati’s departure - Investing.com India
Kenvue names Heather Howlett as interim CFO following Amit Banati’s departure By Investing.com - Investing.com South Africa
Kimberly-Clark names leadership team for Kenvue acquisition - Investing.com
Kenvue Inc. Appoints Heather Howlett as Interim Chief Financial Officer, Effective May 12, 2026 - marketscreener.com
Leadership shift at Kenvue (NYSE: KVUE) as Howlett becomes interim CFO - Stock Titan
Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership - PR Newswire
NUANCE INVESTMENTS, LLC's Kenvue Inc(KVUE) Holding History - GuruFocus
KVUE Maintained by Barclays -- Price Target Lowered to $18.00 - GuruFocus
Listerine Cool Mint: Why Oral Care Stability Matters More Now - AD HOC NEWS
Barclays Maintains Kenvue(KVUE.US) With Hold Rating, Cuts Target Price to $18 - Moomoo
Liquidity Mapping Around (KVUE) Price Events - Stock Traders Daily
Kenvue (NYSE:KVUE) Solidifies Its Position In The S&P 500 Index with Strong Growth - Kalkine Media
Sumitomo Mitsui Trust Group Inc. Grows Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. (NYSE:KVUE) Receives Average Rating of "Hold" from Analysts - MarketBeat
HF Advisory Group LLC Purchases 74,215 Shares of Kenvue Inc. $KVUE - MarketBeat
Massachusetts Financial Services Co. MA Reduces Position in Kenvue Inc. $KVUE - MarketBeat
RBC Capital Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $21 - Moomoo
Alpha Omega Wealth Management LLC Sells 167,069 Shares of Kenvue Inc. $KVUE - MarketBeat
KVUE Stock Price, Quote & Chart | KENVUE INC (NYSE:KVUE) - ChartMill
Assessing Kenvue (NYSE:KVUE) Valuation After New Dermatology Data And Product Launches - simplywall.st
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - MSN
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Sonoma Pharmaceuticals and Kenvue Brands Sign Manufacturing and Supply Agreement for Microcyn® Technology Products Through 2027 - Minichart
Sonoma Pharmaceuticals enters manufacturing agreement with Kenvue Brands - Investing.com
Sonoma Pharmaceuticals (SNOA) signs Kenvue U.S. Microcyn manufacturing and supply deal - Stock Titan
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
2.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):